RENX - Ticker AI Digest

Renalytix AI plc 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (RENX) 1
RENX 15:03
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
AI 1
RENX 06:01
Renalytix AI plc
Tempus AI Inc, collaboration agreement
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Renalytix plc, a precision medicine diagnostics company, has signed a collaboration agreement with Tempus AI Inc. to expand the availability of its **kidneyintelX.dkd** <mark style="background-color:yellow">test</mark> within Tempus’ US healthcare network. The test, which is FDA-approved and Medicare-reimbursed, predicts the risk of progressive kidney function decline in type 2 diabetes patients with chronic kidney disease (CKD) stages 1-3b. This partnership aims to improve patient outcomes by enabling timely interventions and better disease management for the nearly 15 million affected individuals in the US.
Under the agreement, Tempus will integrate kidneyintelX.dkd into its portfolio as its first CKD-focused test, leveraging its AI-enabled platform to enhance clinical workflows and data analysis. Renalytix will process the tests in its laboratories, with results reported electronically to clinicians and patients. Both companies emphasize the collaboration’s potential to drive innovation in diagnostics and therapeutics for cardiovascular, renal, and metabolic conditions.
This partnership marks a significant step in addressing the growing burden of CKD, a costly and prevalent condition, by increasing access to advanced prognostic tools and improving care delivery.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 1
RENX 06:02
Renalytix AI plc
WRAP Retail Offer for up to £500,000
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 13
RENX 15:03
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 16:19
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 13:29
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 08:33
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 06:01
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 11:18
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 06:01
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 17:27
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 06:01
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 16:15
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 15:33
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 11:47
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 10:19
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
RENX 13:01
Renalytix AI plc
Update Regarding Forward Guidance
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 21
RENX 15:03
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 16:19
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 13:29
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 08:33
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 06:01
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 11:18
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 06:01
Renalytix AI plc
£7.05m total gross proceeds from Fundraise
RENX 13:01
Renalytix AI plc
Update Regarding Forward Guidance
RENX 09:01
Renalytix AI plc
Additional Subscription for 11m Shares
RENX 06:01
Renalytix AI plc
Investor Presentation and Revised Revenue Guidance
RENX 16:31
Renalytix AI plc
Result of Fundraise
RENX 06:02
Renalytix AI plc
WRAP Retail Offer for up to £500,000
RENX 06:01
Renalytix AI plc
Proposed Fundraise
RENX 06:01
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 17:27
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 06:01
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 06:01
Renalytix AI plc
Tempus AI Inc, collaboration agreement
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Renalytix plc, a precision medicine diagnostics company, has signed a collaboration agreement with Tempus AI Inc. to expand the availability of its **kidneyintelX.dkd** <mark style="background-color:yellow">test</mark> within Tempus’ US healthcare network. The test, which is FDA-approved and Medicare-reimbursed, predicts the risk of progressive kidney function decline in type 2 diabetes patients with chronic kidney disease (CKD) stages 1-3b. This partnership aims to improve patient outcomes by enabling timely interventions and better disease management for the nearly 15 million affected individuals in the US.
Under the agreement, Tempus will integrate kidneyintelX.dkd into its portfolio as its first CKD-focused test, leveraging its AI-enabled platform to enhance clinical workflows and data analysis. Renalytix will process the tests in its laboratories, with results reported electronically to clinicians and patients. Both companies emphasize the collaboration’s potential to drive innovation in diagnostics and therapeutics for cardiovascular, renal, and metabolic conditions.
This partnership marks a significant step in addressing the growing burden of CKD, a costly and prevalent condition, by increasing access to advanced prognostic tools and improving care delivery.
RENX 16:15
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 15:33
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 11:47
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy
RENX 10:19
Renalytix AI plc
Holding(s) in Company
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
TR1 Buy

AI Crunch

Single-Ticker AI Crunch
RENX signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Renalytix AI plc. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full RENX AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for RENX on 2025-09-30.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
8521864
Enterprise Value
20487663
Public Float
83.16
Broker Target
88
Shares Out
437018680
Long Interest
-
Short Interest
-
Exchange
LSE
Currency Code
GBX
ISIN
GB00BYWL4Y04
Market
LSE - AIM
Sector
-
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
2026-03-16
Net Debt
4700000.0
Cash
3600000.0
EPS
-0.03
Net Income
-20400000.0
Revenue
3000000.0
Enterprise Value
20487663
Trailing PE
-
Forward PE
-
Price Sales TTM
2.5824
Price Book MRQ
8.0648
EV Revenue
3.3375
EV EBITDA
-2.3412

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
45.6428
Institutions As Of
2026-04-09
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
8
Sale Director Dealing
0
Purchase TR1
31
Sale TR1
36
Broker Coverage Rows
0
Institution Holders Tracked
8
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit RENX.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-09-30 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Renalytix AI plc has fresh news flow feeding the chart narrative.
AI Charts Studio
RENX Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-09-30 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast -32.42%
RSI Gauge
Price Change
AI Forecast